Adrian I Abdo is a Postdoctoral Researcher in researching alternative antimicrobial therapies against common healthcare-associated microbes at the University of Adelaide. He is a member of the Organising Committee for TQEH Research Expo at The Queen Elizabeth Hospital, and a member of the Australian Society for Microbiology. He earned his Ph.D. from the University of Sydney in 2018. Throughout his Ph.D., he gained extensive knowledge in cell biochemistry and physiology, particularly in redox signaling and endothelial nitric oxide synthase activity. After completing his Ph.D. studies, he moved to the University of Adelaide to investigate zinc signaling in vascular cells, publishing his findings on which Zinc transport proteins in endothelial and smooth muscle cells respond to changing Zinc status. These results led to an observational study investigating whether polymorphisms in the zinc transport protein, ZIP2, is linked to cardiovascular disease outcomes in cardiology patients that have undergone coronary artery angiography. Since 2021, he has been investigating plasma-activated water as an antimicrobial solution that also promotes wound healing, and has published a book chapter titled "Cold Plasma Therapy as a Physical Antibiofilm Approach" in Antibiofilm Strategies 11th Edition (2022).